Company news
Bluenergies Ltd. news in 2013
Bluenergies Ltd.'s news releases, calls and decks from 2013, newest first.
BELLUS Health reports results for third quarter ended September 30, 2013
November 5, 2013
BELLUS Health and AmorChem Announce a Partnership to Develop Drug Candidates for AL Amyloidosis
October 28, 2013
BELLUS Health Out-Licenses VIVIMIND, BLU8499 and Its Analogs
October 23, 2013
TSX Venture Exchange Daily Bulletins
August 20, 2013
BELLUS Health announces closing of the acquisition of Thallion Pharmaceuticals
August 15, 2013
BELLUS Health reports results for second quarter ended June 30, 2013
August 7, 2013
KIACTA(TM) Granted Orphan Drug Status in Japan
July 23, 2013
BELLUS Health to acquire Thallion Pharmaceuticals
June 18, 2013
BELLUS Health Reports Results for First Quarter Ended March 31, 2013, and Provides Update on KIACTA(TM) Phase III Confirmatory Study
May 15, 2013
BELLUS Health Reports Results for Year Ended December 31, 2012
February 27, 2013